2019 CVD Primary Prevention Guideline
Published: marzo 17, 2019
- The purpose of this guideline is to review and consolidate existing recommendations into a single guidance document focused on the primary prevention of atherosclerotic cardiovascular disease (ASCVD).
- This guideline includes newly generated recommendations for aspirin use, and tobacco use, in addition to recommendations related to team-based care, shared decision-making, exercise and physical activity, and assessment of social determinants of health.
- Recommendations for lifestyle and other factors that affect cardiovascular risk are provided to create a comprehensive yet targeted ACC/AHA guideline on primary prevention of ASCVD.
2019 CVD Primary Prevention Guideline: A Deep Dive
Donna Arnett, MSPH, PhD and Erin Michos, MD, MHS provide an overview of the 2019 CVD Primary Prevention Guideline.
Supporting Materials
- Commentary: What You Need to Know About the New Prevention Guidelines by Penny M. Kris-Etherton, Distinguished Professor of Nutrition, The Pennsylvania State University, Ph.D., R.D.N., L.D.N., FAHA, FNLA, FASN, CLS
- Top Things to Know: : Top Things to Know
- Executive Summary: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- Slide Set (PDF)
- Highlights from the 2019 CVD Primary Prevention Guideline (PDF)
- Commentary: What You Need to Know About the New Prevention Guidelines by Penny M. Kris-Etherton, Distinguished Professor of Nutrition, The Pennsylvania State University, PhD, RDN, LDN, FAHA, FNLA, FASN, CLS
- Data Visualization
- Infographic: Primary Prevention (PNG)
- News Release: ACC/AHA Guidance for Preventing Heart Disease, Stroke Released
- AHA News: New guidelines: Healthy lifestyle, managing risks are key to preventing heart attack, stroke
Related Resources
Related Resources
- Patient Resources
- ASCVD Risk Calculator
- Guidelines-on-the-Go App for IOS
- Guidelines-on-the-Go App for Android
- Guidelines & Statements
Related Science
- 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- 2018 Guideline on the Management of Blood Cholesterol
- 2018 HHS Physical Activity Guidelines for Americans
- 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
- 2017 USPSTF Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Risk Factors: Behavioral Counseling
- 2016 ACC/AHA Guideline on the Management of Patients With Lower-Extremity Peripheral Artery Disease
- 2014 Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
- 2014 Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: U.S. 2014 Preventive Services Task Force Recommendation Statement
- Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
- 2002 AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update
- Recommended Dietary Pattern to Achieve Adherence to the American Heart Association/American College of Cardiology (AHA/ACC) Guidelines
- Low-Calorie Sweetened Beverages and Cardiometabolic Health
- Artificially Sweetened Beverages and Stroke, Coronary Heart Disease, and All-Cause Mortality in the Women’s Health Initiative
- Medical Nutrition Education, Training, and Competencies to Advance Guideline-Based Diet Counseling by Physicians
- Dietary Diversity: Implications for Obesity Prevention in Adult Populations
- Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease
- Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease
- Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool
- Social Determinants of Risk and Outcomes for Cardiovascular Disease
- Sex Differences in the Association Between Measures of General and Central Adiposity and the Risk of Myocardial Infarction: Results From the UK Biobank
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence
- Electronic Cigarettes
- Use of Aspirin to Reduce Risk of Initial Vascular Events in Patients at Moderate Risk of Cardiovascular Disease (ARRIVE): A Randomised, Double-Blind, Placebo-Controlled Trial
- ASCEND Study Collaborative Group. Effects of Aspirin for Primary Prevention in Persons With Diabetes Mellitus
- Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly (ASPREE)
- Value of Primordial and Primary Prevention for Cardiovascular Disease